ISPD 2021 Conference Recordings Library

2021 Conference Registrants receive complimentary access to Conference Recordings. 

2021 Conference Registrants: Access Recordings

Purchase Options

If you did not register for the 2021 Conference, you may purchase recording access. Please review the following rate options. See below for a list of included presentations.

Recording Rates   Member   Non-member  
Full Professional   $110.00 $175.00
Allied Health Professional   $85.00 $145.00
Trainee   $25.00 $25.00

All rates shown in US Dollars.

Bulk Purchases

ISPD is now offering bulk pricing options for organizations interested in providing recordings to larger groups.

Audience Size   Price (USD)  
50 users   $4,500.00  
75 users   $6,000.00  
100 users   $7,000.00  

Purchasers of bulk licenses will be required to submit a list of audience viewers as supporting documentation.

Contact ISPD to request additional information.

Select Rate Below to Purchase:

Skip to search results
Additional Image
Allied Health Professional rates are available to non-doctoral Health Professionals (Nurses, Genetic Counselors, Sonographers, Technologists, Administrators, etc.).
Additional Image
Full Professional rates are available to physicians, scientists, Corporate representatives, and other individuals who are professionally involved, or have an expressed interest, in the field of prenatal diagnosis.
Additional Image
Trainee rate is available to individuals who are enrolled full-time as a resident, fellow or graduate student in a program that will lead to appropriate degrees or certificates in subjects relating to prenatal diagnosis and therapy.

Contents of ISPD 2021 Conference Recordings Library

The following presentations are included in the 2021 Conference Video Library:

Opening Plenary, Top Abstracts
  • Keynote – Genomic Epidemiology of the Pandemic, Judith Breuer
  • Investigating the susceptibility of human fetal tissues to vertical transmission of SARS-CoV2, Joseph Davidson
  • Multicenter prospective study of SNP-based cfDNA for 22q11.2 deletion in 18,290 pregnancies with genetic confirmation, Pe'er Dar
  • Clinical pilot integrating single gene non-invasive prenatal testing (sgNIPT) panel, Sophie Adams
Awards, Machine learning to interpret fetal phenotyping and sequencing data
  • 2021 Award Announcements
  • Machine learning to interpret fetal phenotyping and sequencing data: Lessons learned from pediatrics, Stephen Kingsmore 
Beyond the Karyotype
  • Karyotyping, sequencing and everything in between: Working towards a single all-encompassing test, Brynn Levy
  • Current use of NIPT in Europe, Australia and USA, Joris Vermeesch
  • Alternative Uses of cfDNA in maternal plasma: Beyond assessment of fetal genetic diseases, Rossa Chiu
Debate 1 - All IVF cycles should involve pre-implantation genetic testing to improve fetal health and pregnancy outcomes
  • All IVF cycles should involve pre-implantation genetic testing to improve fetal health and pregnancy outcomes
    • For: David Amor
    • Against: Julian Savulescu
    • Moderator: Louise Wilkins-Haug
Education and Early Career
  • Education in the New Era, Mary Norton
  • Select Best Early Career Abstract Presentation:
    The cell-free DNA virome of 108.349 Dutch pregnant women: Towards NIPT-based early detection of viral infections, Jasper Linthorst
Fetal Therapy - co-sponsored by iFeTIS
  • Treatment of XLHED in utero, Holm Schneider
  • New understandings about the fetal immune system development with relevance to fetal treatment, Naomi McGovern
  • A proposed system for fetal and maternal adverse event grading for fetal therapy clinical trials, Anna David
  • Abstract Presentations:
    • Enhanced Donor Chimerism and Immune Modulation by Paternal Donor Intrauterine Haemopoietic Stem Cell Transplantation in a Murine Model, Citra Mattar
    • Impact of fetal endoscopic tracheal occlusion in fetuses with congenital diaphragmatic hernia and moderate lung hypoplasia, Rogelio Cruz-Martínez
Pioneer Award Lecture
  • The Unexpected: Our Best Teacher, Ron Wapner, 2020 Pioneer Award Recipient
Prenatal Diagnosis Journal Update and Anniversary, Debate 2 - Amniocentesis rather than CVS should be offered to confirm abnormal NIPT results
  • Prenatal Diagnosis Update, Lyn Chitty
  • 40th Anniversary of Prenatal Diagnosis, Diana Bianchi
  • Debate 2 – Amniocentesis rather than CVS should be offered to confirm abnormal NIPT results
    • For: Mark Pertile
    • Against: Diane Van Opstal
    • Moderator: Igna Van den Veyver
Screening for maternal/fetal morbidity
  • Maternal biomarkers in the era of NIPT: What are they worth?, Emmanuel Bujold
  • Screening for CMV, Brenna Hughes
TOTAL Trial and Closing Remarks
  • TOTAL Trial Results, Jan Deprest
  • A FETO Critics Perspective on the TOTAL Trials, Alan Flake